Alfred J Novak - Net Worth and Insider Trading

Alfred J Novak Net Worth

The estimated net worth of Alfred J Novak is at least $626,377 dollars as of 2024-04-26. Alfred J Novak is the Director of LivaNova PLC and owns about 11,368 shares of LivaNova PLC (LIVN) stock worth over $626,377. Details can be seen in Alfred J Novak's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Alfred J Novak has not made any transactions after 2021-11-11 and currently still holds the listed stock(s).

Transaction Summary of Alfred J Novak

Alfred J Novak Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Alfred J Novak owns 3 companies in total, including LivaNova PLC (LIVN) , Dova Pharmaceuticals Inc (DOVA) , and Pasithea Therapeutics Corp (KTTA) .

Click here to see the complete history of Alfred J Novak’s form 4 insider trades.

Insider Ownership Summary of Alfred J Novak

Ticker	Comapny	Transaction Date	Type of Owner
LIVN	LivaNova PLC	2021-11-11	director
DOVA	Dova Pharmaceuticals Inc	2019-11-12	director
KTTA	Pasithea Therapeutics Corp	2022-09-14	director

Alfred J Novak Latest Holdings Summary

Alfred J Novak currently owns a total of 1 stock. Alfred J Novak owns 11,368 shares of LivaNova PLC (LIVN) as of November 11, 2021, with a value of $626,377.

Latest Holdings of Alfred J Novak

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
LIVN	LivaNova PLC	2021-11-11	11,368	55.10	626,377

Holding Weightings of Alfred J Novak

Alfred J Novak Form 4 Trading Tracker

According to the SEC Form 4 filings, Alfred J Novak has made a total of 3 transactions in LivaNova PLC (LIVN) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in LivaNova PLC is the sale of 2,981 shares on November 11, 2021, which brought Alfred J Novak around $266,859.

Insider Trading History of Alfred J Novak

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Alfred J Novak Trading Performance

GuruFocus tracks the stock performance after each of Alfred J Novak's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Alfred J Novak is -4.95%. GuruFocus also compares Alfred J Novak's trading performance to market benchmark return within the same time period. The performance of stocks bought by Alfred J Novak within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Alfred J Novak's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Alfred J Novak

Average Return

72.66%

Average return per transaction

Outperforming Transactions

100%

1 out of 1 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	13.7	-4.95	39.72	72.66	9.6	1.45
Relative Return to S&P 500(%)	10.79	-13.29	21.27	37.49	1.27	-10.72

Alfred J Novak Ownership Network

Ownership Network List of Alfred J Novak

No Data

Ownership Network Relation of Alfred J Novak

Alfred J Novak Owned Company Details

What does LivaNova PLC do?

Who are the key executives at LivaNova PLC?

Alfred J Novak is the director of LivaNova PLC. Other key executives at LivaNova PLC include COO Damien Mcdonald , Chief Legal Officer Michael Damon Hutchinson , and SVP Global Operations & R&D Marco Dolci .

LivaNova PLC (LIVN) Insider Trades Summary

Over the past 18 months, Alfred J Novak made no insider transaction in LivaNova PLC (LIVN). Other recent insider transactions involving LivaNova PLC (LIVN) include a net sale of 4,440 shares made by Damien Mcdonald ,

In summary, during the past 3 months, insiders sold 0 shares of LivaNova PLC (LIVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,440 shares of LivaNova PLC (LIVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,440 shares.

LivaNova PLC (LIVN)'s detailed insider trading history can be found in Insider Trading Tracker table.

LivaNova PLC Insider Transactions

No Available Data

What does Dova Pharmaceuticals Inc do?

Who are the key executives at Dova Pharmaceuticals Inc?

Alfred J Novak is the director of Dova Pharmaceuticals Inc. Other key executives at Dova Pharmaceuticals Inc include 10 percent owner Joseph Edelman , 10 percent owner Perceptive Advisors Llc , and 10 percent owner Perceptive Life Sciences Master Fund Ltd .

Dova Pharmaceuticals Inc (DOVA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Dova Pharmaceuticals Inc (DOVA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dova Pharmaceuticals Inc (DOVA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Dova Pharmaceuticals Inc (DOVA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Dova Pharmaceuticals Inc Insider Transactions

No Available Data

What does Pasithea Therapeutics Corp do?

Who are the key executives at Pasithea Therapeutics Corp?

Alfred J Novak is the director of Pasithea Therapeutics Corp. Other key executives at Pasithea Therapeutics Corp include Chief Development Officer Graeme Martin Currie , 10 percent owner Paul B Manning , and 10 percent owner Bradford Manning .

Pasithea Therapeutics Corp (KTTA) Insider Trades Summary

Over the past 18 months, Alfred J Novak made no insider transaction in Pasithea Therapeutics Corp (KTTA). Other recent insider transactions involving Pasithea Therapeutics Corp (KTTA) include a net purchase of 30,000 shares made by Lawrence Steinman ,

In summary, during the past 3 months, insiders sold 0 shares of Pasithea Therapeutics Corp (KTTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pasithea Therapeutics Corp (KTTA) were sold and 1,500 shares were bought by its insiders, resulting in a net purchase of 1,500 shares.

Pasithea Therapeutics Corp (KTTA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Pasithea Therapeutics Corp Insider Transactions

No Available Data

Alfred J Novak Mailing Address

Above is the net worth, insider trading, and ownership report for Alfred J Novak. You might contact Alfred J Novak via mailing address: 325 Ne 6th St, Boca Raton Fl 33432.

Discussions on Alfred J Novak

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.